Sir, Reply to intravitreal triamcinolone acetonide as treatment of branch retinal vein occlusion
We would like to thank Dr Wilkins for his interest in our study. 1 We do agree with him that the statistical basis of the study is relatively weak. As he pointed out, multiple comparisons were performed so that Bonferoni's method to correct for multiple comparisons might have been necessary. On the other hand, the number of patients in the study group was rather low (n ¼ 10), despite of which the difference in visual acuity between baseline measurement and measurement at 1 month after injection was marginally significant (P ¼ 0.027). Additionally, he difference between visual acuity at baseline of the study and the best visual acuity during follow-up was significant in the study group, but not in the control group. Furthermore, the study fits with other investigations on the intravitreal use of triamcinolone acetonide for a number of diseases associated with cystoid macular oedema including branch retinal vein occlusion. [2] [3] [4] In all of these studies, a decrease in macular oedema, and in most of the studies, an increase in visual acuity was observed. In conclusion, we appreciate very much Dr Wilkins' comments and consider the present study as a precursor of ongoing randomized controlled trials on intravitreal triamcinolone acetonide as treatment of retinal vein occlusions. 
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Case report
A 39-year-old man presented with gradual increased prominence of his left eye, which had suffered a corneal penetrating eye injury from a wooden stick at age 7 years and had undergone primary repair. On examination, best-corrected visual acuities were 6/7.5 OD and perception of light OS. The appearance of the left eye is shown in Figure 1 . Intraocular pressures were 16 mmHg OD and 28 mmHg OS. The left eye was aphakic.
Thyroid function tests were normal. An orbital CT scan revealed an elongated left axial length of 33 mm, compared to 26 mm in the right eye (Figure 2a and b) . There was no evidence of an intraorbital mass or extraocular muscle enlargement.
Comment
Ocular trauma is the leading cause of monocular blindness in children. [1] [2] [3] In a series of 50 eyes that had suffered severe globe rupture and were not removed within 2 weeks of injury, 4 the majority (70%) became phthisical. No eyes developed macrophthalmos.
In normal eyes, after the rapid growth in axial length in the first 5 years of life, a slow juvenile phase lasting until age 13 years results in an increase of only 1.3-1.4 mm. 5 In a series of 13 adult patients with unilateral childhood traumatic cataract, all injured eyes had greater axial lengths than their normal fellow eyes (range 0.1-11.5 mm, mean 2.48 mm). 6 Interestingly, the patient with an injured eye 11.5 mm longer than the normal fellow eye had suffered the injury at age 3 years.
The authors believe that the reported case appears to be the first reported case of severe macrophthalmos following trauma in a juvenile. This could be due to gradual stretching of a biomechanically weakened sclera from previous trauma in response to raised intraocular pressure and extraocular muscle tension. This case suggests that since the dynamic process of emmetropisation continues after the age of 7 years, the axial length might remain malleable, if this process is interrupted by trauma and visual impairment.
